Total Assets
McKesson Total Assets increased by 0.0% to $84.19B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.4%, from $71.08B to $84.19B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 6.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Growth in total assets typically mirrors the overall expansion of the business, provided it is accompanied by corresponding revenue growth.
Detailed definition
The aggregate value of everything the company owns, including both short-term liquid resources and long-term physical an...
Peer comparison
Used to compare the scale of operations across the industry; larger asset bases generally suggest a more dominant market presence.
total_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62.89B | $63.60B | $63.71B | $63.30B | $62.30B | $63.08B | $62.69B | $62.32B | $64.10B | $66.09B | $66.51B | $67.44B | $71.67B | $72.43B | $71.08B | $75.14B | $81.31B | $84.16B | $84.19B |
| QoQ Change | — | +1.1% | +0.2% | -0.6% | -1.6% | +1.3% | -0.6% | -0.6% | +2.8% | +3.1% | +0.6% | +1.4% | +6.3% | +1.1% | -1.9% | +5.7% | +8.2% | +3.5% | +0.0% |
| YoY Change | — | — | — | — | -1.0% | -0.8% | -1.6% | -1.5% | +2.9% | +4.8% | +6.1% | +8.2% | +11.8% | +9.6% | +6.9% | +11.4% | +13.5% | +16.2% | +18.4% |
Business Segments
| Segment | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '24 |
|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | $38.35B | — | — | — | $41.79B | $46.81B |
| International | $13.72B | $10.90B | $9.60B | $6.20B | $6.23B | $6.54B |
| Medical-Surgical Solutions | $5.83B | — | — | — | $5.78B | $6.23B |
| Total | $63.30B | $62.30B | $63.08B | $62.69B | $62.32B | $67.44B |
International, Medical-Surgical Solutions, Prescription Technology Solutions, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Total Assets at Other Companies
Frequently Asked Questions
- What is McKesson's total assets?
- McKesson (MCK) reported total assets of $84.19B in Q4 2025.
- How has McKesson's total assets changed year-over-year?
- McKesson's total assets increased by 18.4% year-over-year, from $71.08B to $84.19B.
- What is the long-term trend for McKesson's total assets?
- Over 5 years (2020 to 2025), McKesson's total assets has grown at a 6.4% compound annual growth rate (CAGR), from $61.85B to $84.19B.
- What does total assets mean?
- The total value of everything the company owns, from cash to buildings.